Compound Screening Libraries
Compound screening libraries are studied by library type, including diversity, focused, fragment, natural product and DNA-encoded collections. The report covers purchase and access models…
Humanized animal models are assessed by model type, covering humanized immune system, liver and gene-humanized mice and rats. Oncology, immunology, infectious disease and drug metabolism studies frame demand, with breeding capacity, custom model services and ethical regulation reviewed by region.
The study gives estimates and forecasts for the global market and for each major region, with country-level analysis where the market warrants it. It profiles the companies that matter in this field and lists the wider supplier base in a corporate directory, together with recent product launches, partnerships, collaborations, mergers and acquisitions.
Strategists, investors, laboratories, contract research and manufacturing organizations, biotechnology and healthcare companies, academic professionals and regulatory teams use our reports to
The full table of contents and list of exhibits come with the sample pages. Request sample pages.
Reports are delivered as a PDF by email within one working day of payment. Payment by invoice. Read the license terms and terms of sale.
Ask for sample pages, a formal quotation for your purchasing team, or put a question to the analyst. Sample pages are sent to organization email addresses only.
Compound screening libraries are studied by library type, including diversity, focused, fragment, natural product and DNA-encoded collections. The report covers purchase and access models…
Organ-on-chip is examined as a technology platform spanning liver, lung, kidney, gut, heart and multi-organ systems. The study covers chips, instruments and services, uses in toxicology and…
AI drug discovery is studied across target identification, molecule design, virtual screening, ADMET prediction and clinical trial design. The report covers software platforms, discovery…
PROTACs and related targeted protein degraders are reviewed from E3 ligase biology to clinical development. The study covers pipeline programs by therapeutic area, chemistry and linker…